Loading insider details...
Latest Form 4 (Nov 17, 2026): Exercise/Conversion of 181 MCRB shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 17, 2026 | Seres Therapeutics, Inc. (MCRB) | Exercise/Conversion | 181 | n/a |
| Aug 18, 2026 | Seres Therapeutics, Inc. (MCRB) | Exercise/Conversion | 181 | n/a |
| Jul 10, 2026 | Seres Therapeutics, Inc. (MCRB) | Grant/Award | 18,750 | n/a |
| May 19, 2026 | Seres Therapeutics, Inc. (MCRB) | Exercise/Conversion | 180 | n/a |
| Mar 11, 2026 | Seres Therapeutics, Inc. (MCRB) | Grant/Award | 56,250 | n/a |